Canopus BioPharma Incorporated
CBIA · OTC
8/31/2022 | 8/31/2021 | 6/30/2014 | 6/30/2013 | |
|---|---|---|---|---|
| Market Cap | $10,962 | $3,930 | $10,178 | $633 |
| - Cash | $4 | $1 | $29 | $0 |
| + Debt | $10 | $0 | $1,851 | $4,059 |
| Enterprise Value | $10,968 | $3,929 | $12,000 | $4,692 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | -$10 | -$10 |
| % Margin | – | – | – | – |
| EBITDA | -$765 | -$2 | -$109 | -$109 |
| % Margin | – | – | – | – |
| Net Income | -$765 | -$2 | -$851 | -$526 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.007 | 0 | -0.021 | -0.025 |
| % Growth | – | 100% | 16.1% | – |
| Operating Cash Flow | -$6 | -$2 | $1,928 | -$544 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$6 | -$2 | $1,928 | -$544 |